LY-267108

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameLY-267108
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMotilin receptor agonists
TargetsMotilin receptor
Therapy Area/IndicationsEsophagitis, Peptic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsEsophagitis, Peptic

Other Information

ATC CodeN/A
Related LinksN/A